Cargando...

Lymphocyte-To-Monocyte Ratio May Serve as a Better Prognostic Indicator Than Tumor-Associated- Macrophages in DLBCL Treated with Rituximab

There are multiple prognostic indicators for Diffuse large B-cell lymphoma (DLBCL) including; the International Prognostic Index (IPI), and gene expression profiling (GEP) to classify the disease into germinal center B-cell and activated B-cell subtypes, the latter harboring inferior prognosis. More...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Appl Immunohistochem Mol Morphol
Autores principales: Matsuki, Eri, Bohn, Olga L., Jamal, Siraj El, Pichardo, Janine D., Zelenetz, Andrew D., Younes, Anas, Teruya-Feldstein, Julie
Formato: Artigo
Lenguaje:Inglês
Publicado: 2019
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6374215/
https://ncbi.nlm.nih.gov/pubmed/30106758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PAI.0000000000000645
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!